Clinical Practice Guideline Open Access
Copyright ©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Jul 21, 2008; 14(27): 4289-4295
Published online Jul 21, 2008. doi: 10.3748/wjg.14.4289
Perspective on the practical indications of endoscopic submucosal dissection of gastrointestinal neoplasms
Mitsuhiro Fujishiro, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan
Author contributions: Fujishiro M is solely responsible for this article.
Correspondence to: Mitsuhiro Fujishiro, MD, PhD, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. mtfujish-kkr@umin.ac.jp
Telephone: +81-3-38155411
Fax: +81-3-58008806
Received: May 30, 2008
Revised: June 23, 2008
Accepted: June 23, 2008
Published online: July 21, 2008

Abstract

Endoscopic submucosal dissection (ESD) is a new endoluminal therapeutic technique involving the use of cutting devices to permit a larger resection of the tissue over the muscularis propria. The major advantages of the technique in comparison with polypectomy and endoscopic mucosal resection are controllable resection size and shape and en bloc resection of a large lesion or a lesion with ulcerative findings. This technique is applied for the endoscopic treatment of epithelial neoplasms in the gastrointestinal tract from the pharynx to the rectum. Furthermore, some carcinoids and submucosal tumors in the gastrointestinal tract are treated by ESD. To determine the indication, two aspects should be considered. The first is a little likelihood of lymph node metastasis and the second is the technical resectability. In this review, practical guidelines of ESD for the gastrointestinal neoplasms are discussed based on the evidence found in the literature.

Key Words: Endoscopic submucosal dissection; Endoscopic mucosal resection; Gastrointestinal neoplasm; Treatment guideline; Lymph node metastasis



GENERAL CONCEPT TO APPLY ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTROINTESTINAL NEOPLASMS

Endoscopic submucosal dissection (ESD) is a new endoluminal therapeutic technique involving the use of cutting devices to permit a larger resection of the tissue over the muscularis propria in three steps: injecting fluid into the submucosa to elevate the lesion from the muscularis propria, precutting the surrounding mucosa of the lesion, and dissecting the connective tissue of the submucosa beneath the lesion. The major advantages of the technique in comparison with polypectomy and endoscopic mucosal resection (EMR) are these: the resected size and shape can be controlled; en bloc resection is possible even for a large lesion; and the lesions with ulcerative findings are also resectable[12]. Retrospective analyses of the comparison between ESD and EMR for the stomach epithelial neoplasms showed that ESD increased en bloc and histologically complete resection rates compared with EMR but was associated with longer average operation times and a higher incidence of intraoperative bleeding and perforation[34].

Two aspects are considered to determine the application of ESD for each lesion by each operator (Figure 1). The first is a little likelihood of lymph node metastasis and the second is the technical resectability. The former has been determined by the large numbers of surgically resected cases in each organ before establishment of ESD and the latter may be determined by the applied technique, the expertise of the operators, the location of the lesions or their characteristics. In terms of technical resectability, en bloc resection is more desirable than piecemeal resection for accurate assessment of the appropriateness of the therapy, because the depth of invasion and lymphovascular infiltration of cancer cells (that are considerable risk factors for nodal metastasis) are not accurately assessed by piecemeal resection. Almost all possible node-negative epithelial neoplasms can be resected en bloc by ESD, when they are treated by very experienced hands. This does not mean that all endoscopic resection should be performed as ESD. Polypectomy or endoscopic mucosal resection (EMR) are beneficial for patients with pedunculated neoplasms or small neoplasms because of the little invasiveness[5]. If the lesions are apparently pre-malignant neoplasms, piecemeal resection by using EMR may be permissible with the best balance of risks and benefits. Surgical organ resection with lymphadenectomy should be applied to those neoplasms with high probability of positive lymph nodes or failure in complete removal by ESD. Recurrent lesions can be also indicated for ESD, if they fulfill the criteria of no nodal metastasis, but indication should be carefully determined considering the risks of accompanying complications.

Figure 1
Figure 1 Algorism for endoscopic submucosal dissection of gastrointestinal neoplasms.
STOMACH EPITHELIAL NEOPLASMS
Aspects of nodal metastasis

Pre-malignant stomach epithelial neoplasms, gastric adenomas, have no nodal metastases. It is still controversial whether we should treat gastric adenomas endoscopically or follow them. A series with a small number of cases with a preoperative diagnosis of pre-malignant lesion revealed that 37% (16/43) of them were finally diagnosed as adenocarcinoma and a lesion > 1 cm was considered to pose a risk of malignancy[6]. Another study revealed that 6.8% (8/118) of cases were finally diagnosed as adenocarcinoma and high-grade dysplasia by endoscopic biopsy was considered to be an independent risk factor for malignancy[7]. Furthermore, preoperative diagnosis of depressed adenoma is considered to represent a higher risk of malignancy than protruding adenoma[8]. So, when the lesions have these characteristics, endoscopic treatments are recommended, similarly to intramucosal carcinomas. Although local recurrence should be taken into account, piecemeal resection by using EMR techniques to remove the apparent gastric adenomas is allowed.

In terms of malignant stomach epithelial neoplasms, the following types of early gastric cancers without lymphovascular infiltration of cancer cells may have little likelihood of nodal metastases: (1) intramucosal, differentiated adenocarcinoma without ulcer findings of any size; (2) intramucosal, differentiated adenocarcinoma with ulcer findings when the lesion is ≤ 3 cm; (3) intramucosal, undifferentiated adenocarcinoma without ulceration when the lesion is ≤ 2 cm; and (4) differentiated adenocarcinoma with minute submucosal penetration (500 micrometers below the muscularis mucosa; sm1) when the lesion is ≤ 3 cm[9].

Technical aspects

When the endoscopists are well trained for ESD, the technical aspects may not restrict indications to perform ESD, based on the above criteria of no nodal metastasis. However, in our opinion, cases of ulcer findings with fusion of the muscle layer and the mucosal layer and cases of undifferentiated adenocarcinoma may be excluded from the indication or be carefully resected, at least until now. The former cases occur in cancers that previously had a deep ulcer extending into the proper muscle layer, where it is difficult to identify the gastric wall plane during submucosal dissection, which increases the possibility of perforation or incomplete resection by ESD[10]. In the latter cases, first, the margin is very unclear and the possibility of incomplete resection is fairly high, second, the clinical course after recurrence may be more miserable than that of differentiated-type, and third, the differentiation between ulcerative finding or biopsy-inducing fibrosis is sometimes difficult, even though small intramucosal undifferentiated adenocarcinoma with ulcer findings may be associated with nodal metastases[9].

ESOPHAGEAL SQUAMOUS EPITHELIAL NEOPLASMS
Aspects of nodal metastases

Low- and high-grade squamous intraepithelial neoplasms, including carcinoma in situ (m1), have no nodal metastases. It is still controversial whether one should treat these intraepithelial neoplasms endoscopically or just follow them. However, when the lesions are diagnosed as high-grade intraepithelial neoplasms, endoscopic treatment is recommended, to avoid future development of invasive carcinoma or to contain foci of invasive carcinoma[1112]. Although local recurrence should be taken into account, piecemeal resection by using EMR techniques to remove the apparent intraepithelial neoplasms is allowed[1315].

Esophageal squamous cell carcinomas invading the lamina propria (m2) pose little risk of nodal metastases. For those invading the muscularis mucosa (m3) and those with minute submucosal invasion (< 200 micrometers below the muscularis mucosa; sm1), the nodal metastases rate is 9.3% and 19.6%, respectively. The nodal metastases rate of m3 or sm1 cancers with 0-II type, < 5 cm, well or moderately differentiated type, and no lymphovascular infiltration of cancer cells is 4.2%[16]. It has been reported that no nodal metastasis was found in patients with sm1, low histologic grades, and no lymphovascular infiltration of cancer cells[17]. Therefore, for patients unwilling to undergo esophagectomy or chemoradiation and patients with comorbid diseases, ESD may be applied taking into consideration the risks of nodal metastases and treatment-related morbidity.

Technical aspects

When the endoscopists are well trained for ESD, the technical aspects by themselves may not restrict indications to perform ESD, except in special circumstances, such as lesions located in the diverticulum. When lesions spreading > 3/4 of circumference are resected as circular or semi-circular resection, post-operative stricture occurs to a high rate[18]. So, it is controversial to treat these lesions endoscopically. However, intensive balloon dilatations or tentative stent insertion may rescue from the stricture.

ESOPHAGEAL BARRETT NEOPLASMS
Aspects of nodal metastasies

Columnar intraepithelial neoplasms have no nodal metastases. Although local recurrence should be taken into account, piecemeal resection by using EMR techniques and additional ablation therapy to remove the apparent intraepithelial neoplasms is allowed[1923].

There are no data about nodal metastases from the large numbers of surgically resected cases due to limited number of cases of esophageal columnar epithelial carcinomas at an early stage, although a small number of cases revealed no nodal metastasis for the intramucosal and sm1 cancer, where sm1 was determined by upper third of the submucosa[24]. There is no consensus whether one should apply to this kind of malignancy the same criteria that are applied to stomach epithelial neoplasms or esophageal squamous epithelial neoplasms as far as the depth of sm1 to be measured. International workshops of esophagogastric neoplasms adopted the cut-off line of 500 micrometers below the deeper muscularis mucosae, similarly to the stomach[2526].

Technical aspects

Similarly to esophageal squamous epithelial neoplasms, the technical aspects by themselves may not restrict indications to carry out ESD, when the endoscopists are well trained for ESD. When lesions spreading > 3/4 of the circumference of the esophagus (a situation which commonly occurs in long segment Barrett epithelium) are resected (with circular or semi-circular resection), post-operative strictures occur at a high rate[1923].

RECTAL EPITHELIAL NEOPLASMS
Aspects of nodal metastases

Pre-malignant rectal epithelial neoplasms, rectal adenomas, have no nodal metastases. From the standpoint of adenoma-carcinoma sequence, all adenomas, including diminutive polyps, are targets for endoscopic resection[2728], although some investigators agree with endoscopic removal only if the size is > 5 mm[29]. En bloc resection is not always necessary for rectal adenoma or intramucosal carcinoma. However, higher rate of local recurrence was reported when multiple resections were performed[3032]. Intramucosal carcinomas and those with slight submucosal invasion (< 1000 micrometers below the muscularis mucosa; sm1) without lymphovascular infiltration have little risk of nodal metastasis[33].

Tumor morphology and surface pit pattern are good endoscopic indicators for submucosal invasion. From this aspect, depressed lesions, laterally spreading tumors of non-granular type (LST-NG) and large protruding tumors are considered as good candidates for ESD because these lesions have a high risk of submucosal invasion, which may be difficult to diagnose preoperatively, and a thorough histopathological assessment of the resected specimen is essential. It is controversial whether one should perform ESD or piecemeal EMR for laterally spreading tumors of granular type (LST-G), because most lesions are intramucosal and the endoscopic prediction of invasiveness is highly feasible[34].

Technical aspects

Even for lesions that meet the criteria above, laparoscopic or open surgery may be selected in some institutions considering the location and size of the lesion. The lesions with submucosal fibrosis due to previous endoscopic treatment or biopsy are also resectable by ESD, even though the indication should be carefully weighed considering risks and benefits of ESD vs surgery[3536]. The rectum is fixed to the retroperitoneum, therefore the endoscope is more easily manoeuvred than in other organs of the gastrointestinal tract. Furthermore, panperitonitis may be less likely than in the rest of the colorectum, even if the muscularis propria is teared, although penetration leads to air accumulation in the retroperitoneal space, which may then spread to a wider area[3738].

COLONIC EPITHELIAL NEOPLASMS
Aspects of nodal metastases

The criteria for absence of nodal metastases are the same as those of rectal epithelial neoplasms (see above).

Technical aspects

There are several tortuous folds in the colon. Peristalsis and residual feces may sometimes disturb ESD procedure. So it is commonly believed that the technical difficulty of colon ESD exceeds those of the stomach, the esophagus, and the rectum, although there are many differences. In all cases, should one consider the substantial risks and expected benefits of ESD. However, promising results of ESD are reported from very experienced endoscopists at advanced institutions, similarly to those of the rectal epithelial neoplasms[3943].

EPITHELIAL NEOPLASMS IN THE SMALL INTESTINE, INCLUDING DUODENUM
Aspects of nodal metastases

Pre-malignant epithelial neoplasms in the small intestine have no nodal metastases. Although local recurrence should be taken into account, piecemeal resection by using EMR techniques and ablation therapy to remove the apparent intraepithelial neoplasms is allowed[44]. There are no data about nodal metastases from the large numbers of surgically resected cases due to limited number of cases of epithelial carcinomas in the small intestine. There is no consensus whether one should apply the same criteria of stomach epithelial neoplasms or colorectal epithelial neoplasms to this malignancy.

Technical aspects

The small intestine, including the duodenum, is considered to be the most difficult organ where to perform ESD. The endoscope does not easily reach the target lesion and the organ is not fixed tightly except at the level of the duodenum, which results in fairly bad maneuverability. Peristalsis is the most active and the wall is the thinnest among the other gastrointestinal organs. Even is the resection is completed successfully, pancreatic juice and bile cause chemical damage to the mucosal wound, which may lead to prolonged bleeding and perforation. In our opinion, closure of the mucosal wound is recommended after ESD. When considering these issues, indication to perform ESD in the small intestine should be carefully assessed and limited. Due to the structural specificity of the papilla, ESD for ampullary neoplasms is not performed.

PHARYNGEAL EPITHELIAL NEOPLASMS
Aspects of nodal metastasis

Pre-malignant epithelial pharyngeal neoplasms have no nodal metastases. Although local recurrence should be taken into account, piecemeal resection by using EMR techniques and ablation therapy to remove the apparent intraepithelial neoplasms is permissible[45]. There are no data about nodal metastasis from the large numbers of surgically resected cases due to limited number of cases of pharyngeal epithelial carcinomas at an early stage. So, indication for invasive carcinoma is still controversial due to the lack of data. Owing to the structural differences, it is impossible to apply the criteria of esophageal squamous epithelial carcinomas for this malignancy.

Technical aspects

ESD is technically possible in this organ, and ESD may be the optimal endoscopic treatment not only because it enables an en bloc resection but also because it can prevent removal of excess mucosa of the pharynx, which is a very narrow and important organ related to swallowing and speech[46].

CARCINOID
Aspects of nodal metastasis

Carcinoids are classified based on organ site and cell of origin and occur most frequently in the gastrointestinal tract (67%) where they are most common in small intestine (25%), appendix (12%), and rectum (14%)[47]. Primary size > 2 cm, serosal penetration, and primary site in the small intestine are considered to be risk factors for metastases in the case of gastrointestinal carcinoids[48].

Nodal metastases are most commonly found with small intestine carcinoids (20%-45%), providing the rationale for an extended resection including the adjacent lymph node drainage area. Carcinoids of the appendix < 1 cm rarely metastasize, simply requiring appendectomy for treatment. Rectal carcinoids < 2 cm rarely metastasize, directing local excision, including endoscopic resection[49]. Another group revealed that colorectal carcinoids < 1 cm without lymphovascular infiltration could be curatively treated by local resection, but others would need radical nodal dissection[50]. Duodenal carcinoids < 2 cm may be excised locally because they rarely metastasize[51].

Multiple gastric carcinoids, usually no more than 1 cm, can be followed up by endoscopy and biopsy[5253]. Sporadic gastric carcinoids should be treated by gastrectomy with lymphadenectomy, because some of those have nodal metastases even when they have a small size[5456]. However, differentiation of types of gastric carcinoids is not always easy, so endoscopic resection, as a first step to obtain histology, may be acceptable for small gastric carcinoids < 1 cm to predict nodal metastases.

Technical aspects

Because almost all lesions for local resection are less than 1 cm in all the gastrointestinal organs, band ligation resection[5758], cap-technique[59] or strip biopsy[6062] result in good outcome. So the application of ESD for carcinoids may be limited. When the lesions are in intermediate size, such as 1-2 cm, or invade massively the submucosal layer, which may result in tumor-positive margin resection, ESD should be applied[3663].

SUBMUCOSAL TUMOR
Aspects of metastases

Submucosal tumors (SMTs) are mesenchymal tumors, which may have very diverse origins. SMTs are classified and defined as benign or malignant based on a combination of size, histological, immunohistochemical, and ultrastructural criteria. The majority of them are classified into gastrointestinal stromal tumor (GIST), of muscular origin, of neurogenic origin, of vascular origin, and of adipose tissue origin. SMTs < 3 cm are generally considered benign tumors. SMTs > 3 cm with high mitotic counts are considered tumors at high-risk of malignancy. In case of GIST, the cutoff of the size between pre-malignancy and malignancy may be 2 cm. Sarcomas including malignant GIST generally do not metastasize to regional lymph nodes, but instead spread hematogenously to the liver or metastasize to the peritoneum[64]. Benign SMTs should generally only be treated if they are symptomatic. So the SMTs > 2 cm or 3 cm without evidence of metastasis may be candidates for local resection[65].

Technical aspects

From the rationale of ESD, the targets should originate from over the muscularis propria. The lesions originating from the inner layer of the muscularis propria may be resectable by careful resection over the outer layer of the muscularis propria, but the high probability of perforation and the artificial peritoneal dissemination by tear of the tumor capsule should be taken into consideration. When considering that the small size lesions located in the mucosal or submucosal layers are mostly benign, the indication of ESD for SMTs is quite limited, although some investigators reported promising results of ESD for SMTs[6667].

FUTURE PERSPECTIVES

The perspectives on the current indication of ESD are described based on a review of data available in the literature until the end of 2007. Further investigations in both aspects, the assessment of nodal metastases and the technical innovations, may change widely the above perspectives in the future. Recently, a new application of ESD is being investigated in cooperation with laparoscopic surgeons for the treatment of possible node-positive gastric carcinoma and gastric GIST[6869]. There is no doubt that these attempts will expand ESD into a new field, which will be added to the upcoming practical guidelines for ESD.

Footnotes

Peer reviewer: Dr. Peter Draganov, University of Florida, 1600 SW Archer Rd., Gainesville, FL 32610, United States

References
1.  Fujishiro M. Endoscopic submucosal dissection for stomach neoplasms. World J Gastroenterol. 2006;12:5108-5112.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Kakushima N, Fujishiro M. Endoscopic submucosal dissection for gastrointestinal neoplasms. World J Gastroenterol. 2008;14:2962-2967.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Watanabe K, Ogata S, Kawazoe S, Watanabe K, Koyama T, Kajiwara T, Shimoda Y, Takase Y, Irie K, Mizuguchi M. Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc. 2006;63:776-782.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, Yoshihara M, Chayama K. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc. 2006;64:877-883.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Lee JH, Kim JJ. Endoscopic mucosal resection of early gastric cancer: Experiences in Korea. World J Gastroenterol. 2007;13:3657-3661.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Katsube T, Konnno S, Hamaguchi K, Shimakawa T, Naritaka Y, Ogawa K, Aiba M. The efficacy of endoscopic mucosal resection in the diagnosis and treatment of group III gastric lesions. Anticancer Res. 2005;25:3513-3516.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Park DI, Rhee PL, Kim JE, Hyun JG, Kim YH, Son HJ, Kim JJ, Paik SW, Rhee JC, Choi KW. Risk factors suggesting malignant transformation of gastric adenoma: univariate and multivariate analysis. Endoscopy. 2001;33:501-506.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Tamai N, Kaise M, Nakayoshi T, Katoh M, Sumiyama K, Gohda K, Yamasaki T, Arakawa H, Tajiri H. Clinical and endoscopic characterization of depressed gastric adenoma. Endoscopy. 2006;38:391-394.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219-225.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Fujishiro M, Goto O, Kakushima N, Kodashima S, Muraki Y, Omata M. Endoscopic submucosal dissection of stomach neoplasms after unsuccessful endoscopic resection. Dig Liver Dis. 2007;39:566-571.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, Qiao YL, Mark SD, Dong ZW, Taylor PR. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut. 2005;54:187-192.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Shimizu Y, Kato M, Yamamoto J, Ono Y, Katsurada T, Ono S, Mori Y, Nakagawa M, Nakagawa S, Itoh T. Histologic results of EMR for esophageal lesions diagnosed as high-grade intraepithelial squamous neoplasia by endoscopic biopsy. Gastrointest Endosc. 2006;63:16-21.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Pech O, May A, Gossner L, Rabenstein T, Manner H, Huijsmans J, Vieth M, Stolte M, Berres M, Ell C. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy. 2007;39:30-35.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Pech O, Gossner L, May A, Vieth M, Stolte M, Ell C. Endoscopic resection of superficial esophageal squamous-cell carcinomas: Western experience. Am J Gastroenterol. 2004;99:1226-1232.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432-439.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Oyama T, Miyata Y, Shimatani S, Tomori A, Hotta K, Yoshida M. Diagnosis and Long-term Results and Prognosis of m3 and sm1 Esophageal Cancer. Lymph Nodal Metastasis of m3, sm1 Esophageal Cancer [in Japanese with English abstract]. Stomach Intestine. 2002;37:71-74.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Tajima Y, Nakanishi Y, Ochiai A, Tachimori Y, Kato H, Watanabe H, Yamaguchi H, Yoshimura K, Kusano M, Shimoda T. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285-1293.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Fujishiro M, Yahagi N, Kakushima N, Kodashima S, Muraki Y, Ono S, Yamamichi N, Tateishi A, Shimizu Y, Oka M. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688-694.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc. 2001;54:682-688.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Seewald S, Akaraviputh T, Seitz U, Brand B, Groth S, Mendoza G, He X, Thonke F, Stolte M, Schroeder S. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc. 2003;57:854-859.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Giovannini M, Bories E, Pesenti C, Moutardier V, Monges G, Danisi C, Lelong B, Delpero JR. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy. 2004;36:782-787.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc. 2000;52:328-332.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc. 2007;65:3-10.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004;60:703-710.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3-S43.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Paris Workshop on Columnar Metaplasia in the Esophagus and the Esophagogastric Junction, Paris, France, December 11-12 2004. Endoscopy. 2005;37:879-920.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Unal H, Selcuk H, Gokcan H, Tore E, Sar A, Korkmaz M, Bilezikci B, Demirhan B, Gur G, Yilmaz U. Malignancy risk of small polyps and related factors. Dig Dis Sci. 2007;52:2796-2799.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Kapsoritakis AN, Potamianos SP, Koukourakis MI, Tzardi M, Mouzas IA, Roussomoustakaki M, Alexandrakis G, Kouroumalis EA. Diminutive polyps of large bowel should be an early target for endoscopic treatment. Dig Liver Dis. 2002;34:137-140.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Butterly LF, Chase MP, Pohl H, Fiarman GS. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol. 2006;4:343-348.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Iishi H, Tatsuta M, Iseki K, Narahara H, Uedo N, Sakai N, Ishikawa H, Otani T, Ishiguro S. Endoscopic piecemeal resection with submucosal saline injection of large sessile colorectal polyps. Gastrointest Endosc. 2000;51:697-700.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Tamura S, Nakajo K, Yokoyama Y, Ohkawauchi K, Yamada T, Higashidani Y, Miyamoto T, Ueta H, Onishi S. Evaluation of endoscopic mucosal resection for laterally spreading rectal tumors. Endoscopy. 2004;36:306-312.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Tanaka S, Haruma K, Oka S, Takahashi R, Kunihiro M, Kitadai Y, Yoshihara M, Shimamoto F, Chayama K. Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc. 2001;54:62-66.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H, Kumamoto T, Ishiguro S, Kato Y, Shimoda T. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39:534-543.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Uraoka T, Saito Y, Matsuda T, Ikehara H, Gotoda T, Saito D, Fujii T. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut. 2006;55:1592-1597.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, Kobayashi K, Hashimoto T, Yamamichi N, Tateishi A. Endoscopic submucosal dissection for rectal epithelial neoplasia. Endoscopy. 2006;38:493-497.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Onozato Y, Kakizaki S, Ishihara H, Iizuka H, Sohara N, Okamura S, Mori M, Itoh H. Endoscopic submucosal dissection for rectal tumors. Endoscopy. 2007;39:423-427.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Fu KI, Sano Y, Kato S, Fujii T, Sugito M, Ono M, Saito N, Kawashima K, Yoshida S, Fujimori T. Pneumoscrotum: a rare manifestation of perforation associated with therapeutic colonoscopy. World J Gastroenterol. 2005;11:5061-5063.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Damore LJ 2nd, Rantis PC, Vernava AM 3rd, Longo WE. Colonoscopic perforations. Etiology, diagnosis, and management. Dis Colon Rectum. 1996;39:1308-1314.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Hurlstone DP, Atkinson R, Sanders DS, Thomson M, Cross SS, Brown S. Achieving R0 resection in the colorectum using endoscopic submucosal dissection. Br J Surg. 2007;94:1536-1542.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Tanaka S, Oka S, Kaneko I, Hirata M, Mouri R, Kanao H, Yoshida S, Chayama K. Endoscopic submucosal dissection for colorectal neoplasia: possibility of standardization. Gastrointest Endosc. 2007;66:100-107.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Saito Y, Uraoka T, Matsuda T, Emura F, Ikehara H, Mashimo Y, Kikuchi T, Fu KI, Sano Y, Saito D. Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest Endosc. 2007;66:966-973.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Tamegai Y, Saito Y, Masaki N, Hinohara C, Oshima T, Kogure E, Liu Y, Uemura N, Saito K. Endoscopic submucosal dissection: a safe technique for colorectal tumors. Endoscopy. 2007;39:418-422.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Fujishiro M, Yahagi N, Kakushima N, Kodashima S, Muraki Y, Ono S, Yamamichi N, Tateishi A, Oka M, Ogura K. Outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms in 200 consecutive cases. Clin Gastroenterol Hepatol. 2007;5:678-683; quiz 645.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Oka S, Tanaka S, Nagata S, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Haruma K, Chayama K. Clinicopathologic features and endoscopic resection of early primary nonampullary duodenal carcinoma. J Clin Gastroenterol. 2003;37:381-386.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Fujishiro M, Yamaguchi H, Nakanishi Y, Ooyama W, Watanabe H, Gotoda T, Ono H, Kozu T, Kondo H, Saito D. Application of endoscopic mucosal resection for hypopharyngeal cancer. Digestive Endoscopy. 2001;13:220-224.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Shimizu Y, Yamamoto J, Kato M, Yoshida T, Hirota J, Ono Y, Nakagawa M, Nakagawa S, Oridate N, Asaka M. Endoscopic submucosal dissection for treatment of early stage hypopharyngeal carcinoma. Gastrointest Endosc. 2006;64:255-259; discussion 260-262.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717-1751.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Eller R, Frazee R, Roberts J. Gastrointestinal carcinoid tumors. Am Surg. 1991;57:434-437.  [PubMed]  [DOI]  [Cited in This Article: ]
49.  Stinner B, Kisker O, Zielke A, Rothmund M. Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg. 1996;20:183-188.  [PubMed]  [DOI]  [Cited in This Article: ]
50.  Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007;56:863-868.  [PubMed]  [DOI]  [Cited in This Article: ]
51.  Zyromski NJ, Kendrick ML, Nagorney DM, Grant CS, Donohue JH, Farnell MB, Thompson GB, Farley DR, Sarr MG. Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg. 2001;5:588-593.  [PubMed]  [DOI]  [Cited in This Article: ]
52.  Rappel S, Altendorf-Hofmann A, Stolte M. Prognosis of gastric carcinoid tumours. Digestion. 1995;56:455-462.  [PubMed]  [DOI]  [Cited in This Article: ]
53.  Hosokawa O, Kaizaki Y, Hattori M, Douden K, Hayashi H, Morishita M, Ohta K. Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis. Gastric Cancer. 2005;8:42-46.  [PubMed]  [DOI]  [Cited in This Article: ]
54.  Shinohara T, Ohyama S, Nagano H, Amaoka N, Ohta K, Matsubara T, Yamaguchi T, Yanagisawa A, Kato Y, Muto T. Minute gastric carcinoid tumor with regional lymph node metastasis. Gastric Cancer. 2003;6:262-266.  [PubMed]  [DOI]  [Cited in This Article: ]
55.  Xie SD, Wang LB, Song XY, Pan T. Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature. World J Gastroenterol. 2004;10:2461-2463.  [PubMed]  [DOI]  [Cited in This Article: ]
56.  Suganuma K, Otani Y, Furukawa T, Saikawa Y, Yoshida M, Kubota T, Kumai K, Kameyama K, Mukai M, Kitajima M. Gastric carcinoid tumors with aggressive lymphovascular invasion and lymph node metastasis. Gastric Cancer. 2003;6:255-261.  [PubMed]  [DOI]  [Cited in This Article: ]
57.  Sakata H, Iwakiri R, Ootani A, Tsunada S, Ogata S, Ootani H, Shimoda R, Yamaguchi K, Sakata Y, Amemori S. A pilot randomized control study to evaluate endoscopic resection using a ligation device for rectal carcinoid tumors. World J Gastroenterol. 2006;12:4026-4028.  [PubMed]  [DOI]  [Cited in This Article: ]
58.  Ono A, Fujii T, Saito Y, Matsuda T, Lee DT, Gotoda T, Saito D. Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device. Gastrointest Endosc. 2003;57:583-587.  [PubMed]  [DOI]  [Cited in This Article: ]
59.  Nagai T, Torishima R, Nakashima H, Ookawara H, Uchida A, Kai S, Sato R, Murakami K, Fujioka T. Saline-assisted endoscopic resection of rectal carcinoids: cap aspiration method versus simple snare resection. Endoscopy. 2004;36:202-205.  [PubMed]  [DOI]  [Cited in This Article: ]
60.  Higashino K, Iishi H, Narahara H, Uedo N, Yano H, Ishiguro S, Tatsuta M. Endoscopic resection with a two-channel videoendoscope for gastric carcinoid tumors. Hepatogastroenterology. 2004;51:269-272.  [PubMed]  [DOI]  [Cited in This Article: ]
61.  Ichikawa J, Tanabe S, Koizumi W, Kida Y, Imaizumi H, Kida M, Saigenji K, Mitomi H. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy. 2003;35:203-206.  [PubMed]  [DOI]  [Cited in This Article: ]
62.  Perng CL, Lin HJ, Wang K, Lai CR, Lee SD. Treatment of duodenal carcinoid by strip biopsy. J Clin Gastroenterol. 1995;20:168-171; discussion 171-172.  [PubMed]  [DOI]  [Cited in This Article: ]
63.  Fujishiro M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Ono S, Kobayashi K, Hashimoto T, Yamamichi N, Tateishi A. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006;63:243-249.  [PubMed]  [DOI]  [Cited in This Article: ]
64.  Ponsaing LG, Kiss K, Hansen MB. Classification of submucosal tumors in the gastrointestinal tract. World J Gastroenterol. 2007;13:3311-3315.  [PubMed]  [DOI]  [Cited in This Article: ]
65.  Ponsaing LG, Hansen MB. Therapeutic procedures for submucosal tumors in the gastrointestinal tract. World J Gastroenterol. 2007;13:3316-3322.  [PubMed]  [DOI]  [Cited in This Article: ]
66.  Lee IL, Lin PY, Tung SY, Shen CH, Wei KL, Wu CS. Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer. Endoscopy. 2006;38:1024-1028.  [PubMed]  [DOI]  [Cited in This Article: ]
67.  Rosch T, Sarbia M, Schumacher B, Deinert K, Frimberger E, Toermer T, Stolte M, Neuhaus H. Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy. 2004;36:788-801.  [PubMed]  [DOI]  [Cited in This Article: ]
68.  Abe N, Mori T, Takeuchi H, Yoshida T, Ohki A, Ueki H, Yanagida O, Masaki T, Sugiyama M, Atomi Y. Laparoscopic lymph node dissection after endoscopic submucosal dissection: a novel and minimally invasive approach to treating early-stage gastric cancer. Am J Surg. 2005;190:496-503.  [PubMed]  [DOI]  [Cited in This Article: ]
69.  Hiki N, Yamamoto Y, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M, Miki A, Ohyama S, Seto Y. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc. 2008;22:1729-1735.  [PubMed]  [DOI]  [Cited in This Article: ]